| Prevalence and associations of metabolic syndrome in patients with alcohol use disorder A Hernández-Rubio, A Sanvisens, F Bolao, I Cachón-Suárez, ... Scientific reports 12 (1), 2625, 2022 | 16 | 2022 |
| Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder A Hernández-Rubio, A Sanvisens, F Bolao, C Pérez-Mañá, ... Scientific reports 10 (1), 20060, 2020 | 11 | 2020 |
| Long-term outcomes of patients with cocaine use disorder: a 18-years addiction cohort study A Sanvisens, A Hernández-Rubio, P Zuluaga, D Fuster, E Papaseit, ... Frontiers in Pharmacology 12, 625610, 2021 | 9 | 2021 |
| Increased natural killer cells are associated with alcohol liver fibrosis and with T cell and cytotoxic subpopulations change P Zuluaga, A Teniente-Serra, D Fuster, B Quirant-Sánchez, ... Journal of clinical medicine 11 (2), 305, 2022 | 7 | 2022 |
| Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study A Sanvisens, I Rivas, E Faure, N Espinach, A Hernandez-Rubio, X Majó, ... World Journal of Gastroenterology 26 (38), 5874, 2020 | 6 | 2020 |
| Markers of monocyte activation, inflammation, and microbial translocation are associated with liver fibrosis in alcohol use disorder D Fuster, X Garcia-Calvo, O Farré, P Zuluaga, F Bolao, A Leis, ... Journal of Clinical Medicine 10 (16), 3496, 2021 | 2 | 2021 |
| Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder A Hernández-Rubio, A Sanvisens, L Barbier-Torres, R Blanes, L Miquel, ... Drug and alcohol dependence 245, 109822, 2023 | 1 | 2023 |
| Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment D Fuster, X Garcia-Calvo, F Bolao, P Zuluaga, G Rocamora, ... Drug and Alcohol Dependence 216, 108231, 2020 | 1 | 2020 |
| Multiplatform web app (My Way Up) plus motivational interviewing for improving treatment retention in patients with onset of alcohol-related liver disease and alcohol use … E Caballeria, M Balcells-Oliveró, R Bataller, P Bruguera, N Cabrera, ... Digital health 10, 20552076241242787, 2024 | | 2024 |
| Vitamin D Deficiency Is Associated with Advanced Liver Fibrosis and Impaired Fasting Glucose in Alcohol Use Disorder P Zuluaga, J Casado-Carbajo, A Hernández-Rubio, M Bueno-Vélez, ... Nutrients 16 (8), 1099, 2024 | | 2024 |
| Fungal plasma biomarkers in patients admitted for inpatient treatment of alcohol use disorder D Fuster, C Llorente, X Garcia‐Calvo, F Bolao, P Zuluaga, ... Alcohol: Clinical and Experimental Research 47 (8), 1582-1589, 2023 | | 2023 |
| Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder (vol 10, 20060, 2020): Association of hyperuricemia and gamma … C Pérez-Mañá, R Muga, A Hernandez-Rubio, A Sanvisens, F Bolao, ... Scientific Reports 13, 4244, 2023 | | 2023 |
| Author Correction: Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder A Hernández‑Rubio, A Sanvisens, F Bolao, C Pérez‑Mañá, ... Scientific reports 13, 2023 | | 2023 |
| FUNGAL PERMEABILITY IN PATIENTS ADMITTED FOR HOSPITAL TREATMENT OF ALCOHOL USE DISORDER D Fuster, XG Calvo, F Bolao, P Zuluaga, A Hernandez-Rubio, J Casado, ... HEPATOLOGY 76, S932-S932, 2022 | | 2022 |
| ASSOCIATIONS OF ADVANCED LIVER FIBROSIS IN PATIENTS ADMITTED TO FIRST TREATMENT OF ALCOHOL USE DISORDER P Zuluaga, A Hernandez-Rubio, A Short, L Miquel, M Torrens, G Rubio, ... HEPATOLOGY 76, S116-S116, 2022 | | 2022 |
